Header Logo

Connection

Lynn Morris to Administration, Intravenous

Back to Details
This is a "connection" page, showing publications Lynn Morris has written about Administration, Intravenous.
Lynn Morris
Connection Strength
0,054
Administration, Intravenous
  1. Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial. Lancet HIV. 2023 04; 10(4):e230-e243.
    View in: PubMed
    Score: 0,054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.